In our analysis, RECQL4 expression showed divergent patterns across tumor types, being upregulated in HGG but reduced in MPNST, particularly NF1-associated cases, suggesting that its biological role and potential as a therapeutic target may be context-dependent. The gene discussed is RECQL4; the disease is malignant peripheral nerve sheath tumor.